Literature DB >> 16004986

Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages.

Chinuyo Sumita1, Masako Yamane, Takahisa Matsuda, Makiko Maeda, Tetsuro Nariai, Yasushi Fujio, Junichi Azuma.   

Abstract

In the process of atherosclerosis, platelet activating factor (PAF) promotes the infiltration of inflammatory cells into atherosclerotic plaque by modulating their cytoskeleton. Here, we examined whether Rho family proteins are involved in PAF-induced cytoskeletal reorganization in THP-1 macrophages. PAF stimulation rapidly induced cell elongation, accompanied by filopodia formation. The inhibition of Rho family proteins by the overexpression of Rho-GDI attenuated the PAF-mediated morphological changes. Both RhoA and Cdc42 were activated in response to PAF. Inhibition of RhoA or Cdc42 by dominant negative mutants abrogated morphological changes induced by PAF. Collectively, PAF regulates cytoarchitecture through Rho family proteins in macrophages.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16004986     DOI: 10.1016/j.febslet.2005.06.022

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy.

Authors:  Anil V Nair; Berthold Hocher; Sjoerd Verkaart; Femke van Zeeland; Thiemo Pfab; Torsten Slowinski; You-Peng Chen; Karl Peter Schlingmann; André Schaller; Sabina Gallati; René J Bindels; Martin Konrad; Joost G Hoenderop
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

2.  Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins.

Authors:  Carey N Lumeng; Stephanie M Deyoung; Alan R Saltiel
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-08-22       Impact factor: 4.310

3.  EGF increases TRPM6 activity and surface expression.

Authors:  Stéphanie Thebault; R Todd Alexander; Wouter M Tiel Groenestege; Joost G Hoenderop; René J Bindels
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

4.  Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes.

Authors:  Debashis Nandy; Yan W Asmann; Debabrata Mukhopadhyay; Ananda Basu
Journal:  J Cell Mol Med       Date:  2009-09-14       Impact factor: 5.310

5.  E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus.

Authors:  Michael A Thomas; Robin S Broughton; Felicia D Goodrum; David A Ornelles
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

6.  Platelet-Activating Factor-Induced Reduction in Contact Hypersensitivity Responses Is Mediated by Mast Cells via Cyclooxygenase-2-Dependent Mechanisms.

Authors:  Jesus A Ocana; Eric Romer; Ravi Sahu; Sven-Christian Pawelzik; Garret A FitzGerald; Mark H Kaplan; Jeffrey B Travers
Journal:  J Immunol       Date:  2018-04-25       Impact factor: 5.422

Review 7.  Inflammation, not Cholesterol, Is a Cause of Chronic Disease.

Authors:  Alexandros Tsoupras; Ronan Lordan; Ioannis Zabetakis
Journal:  Nutrients       Date:  2018-05-12       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.